In fiscal year 2025, Curiox Biosystems (445680) reported revenue of 5.2 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 5.2 billion KRW | -12.3 billion KRW | -27.2 billion KRW | [source] |
| 2024 | 4.6 billion KRW | -13.4 billion KRW | -8.1 billion KRW | [source] |
| 2023 | 6.8 billion KRW | -10.6 billion KRW | -10.0 billion KRW | [source] |
| 2022 | 7.2 billion KRW | -11.4 billion KRW | -11.5 billion KRW | — |
| 2021 | 5.5 billion KRW | -8.3 billion KRW | -14.5 billion KRW | — |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 90.9 billion KRW | 22.7 billion KRW | 68.3 billion KRW | [source] |
| 2024 | 79.7 billion KRW | 18.8 billion KRW | 60.9 billion KRW | [source] |
| 2023 | 65.5 billion KRW | 1.8 billion KRW | 63.7 billion KRW | [source] |
| 2022 | — | — | — | — |
| 2021 | — | — | — | — |
Years without a source link are outside the DART financial API collection period.
Balance sheet figures for the relevant year were not collected.